Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2024-08-09 00:00:00 ET · period of report 2023-08-08 · accession 0001062993-24-014792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-09 | 2023-08-08+ | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $14.98 | -2,933 | 18.8K | -14% | -$43.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-08 | F | D | 1,467 | $17.23 | 25,533 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022. (F2) Such amount excludes securities acquired or disposed of subsequent to August 8, 2023. |
| 2 | Common | Common Stock | 2024-08-08 | F | D | 1,466 | $12.73 | 18,784 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022. |